Today

Agents

Chat

Arena

Discover

More

App

Rani Therapeutics files Form 3 for director Michelle Gilson - RANI News | Rallies

Rani Therapeutics files Form 3 for director Michelle Gilson

RANI•2026-08-05

Form 3 filing for director Michelle Gilson

Rani Therapeutics director Michelle Gilson filed an initial Form 3 disclosing a fully vested option for 12,500 Class A shares at USD 7.46.

Related News

Trump advisers tell AI firms they will not safety-test open-weight models

QQQ•2026-08-04

Alzamend Neuro initial beneficial ownership filing names Hyperscale Data as director by deputization

ALZN•2026-08-05

Canada's Dream Industrial REIT Q2 net rental income up on portfolio growth

XLRE•2026-08-04

Sources

S

Rani Therapeutics files Form 3 for director Michelle Gilson

Sec

DaVita flags lower revenue per treatment, reaffirms annual forecast

DVA•2026-08-04

Japan's services growth slows amid cost pressures, PMI shows

EWJ•2026-08-05